SynthesisInternational ophthalmology2026
The relationship between diabetic retinopathy and intestinal microbiota: a systematic review and meta analysis.
Synthesis in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe results of human observational studies on the correlation between gut microbiota and diabetic retinopathy (DR) are discrepant. This meta-analysis aimed to evaluate the specificity of the gut microbiota in DR patients compared to patients with type 2 diabetes mellitus (T2DM).
methodsAll published literature up to October 2024 was searched by two researchers on PubMed, Embase and Web of Science databases. Diversity and gut microbiota composition were the main outcomes. The meta-analysis was conducted in Review Manager (RevMan) Version 5.3.
resultsEight studies, investigating gut microbiota by collecting stool samples, conducted in China and India were included in this meta-analysis, involving a total of 486 individuals in the T2DM (n = 258) and DR (n = 228) groups. No significant difference in alpha-diversity was observed between T2DM and DR patients. The pooled estimate showed that, at the phylum level, the abundances of Patescibacteria, and Synergistetes were significantly lower, and Verrucomicrobia were considerably higher in DR patients than in T2DM patients. At the genus level, DR patients had an increase in Bacteroides compared to T2DM.
conclusionsIn this meta-analysis with a small number of studies and relatively high heterogeneity, changes in gut microbiota were associated with DR, commonly reflected by a reduction in beneficial species and an increase in pathogenic species influencing metabolic pathways.
Indexed as
Identifiers
42418021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.